Sharing research & supporting development of future neurology leaders at AAN 2018
Posted by
23-Apr-2018
UCB will again be playing an important role at this year’s American Academy of Neurology (AAN) Annual Meeting, which takes place in Los Angeles, California, between 21 to 28 April.
Celebrating 70 years at the cutting edge of science and medicine, the AAN meeting is one of the most important and influential neurology gatherings in the world. It provides the global neurology community an opportunity to engage with and discuss exciting and cutting-edge science and research.
The meeting is also an ideal venue for organisations like UCB to engage with the experts from around the world – scientists, clinicians, healthcare providers and advocacy partners - and to discuss with them with the very latest research and thinking about our therapies and management approaches for diseases such as epilepsy, Parkinson's and restless legs syndrome (RLS).
As well as sharing our latest scientific research, this year, we are very proud to be supporting a number of AAN training and leadership initiatives.
UCB is pleased to sponsor the AAN Palatucci Advocacy Leadership Forum. This program builds neurologists’ capacity to advocate for the interests of their patients at the National and State levels. By completing this program neurologists are equipped to use media and public affairs strategies on real-time public policy issues that impact patients and providers.
The AAN Diversity Leadership immersion program identifies, orients and cultivates underrepresented minorities. During an interactive 9-month program, participants receive mentoring and executive coaching to improve their leadership skills, allowing them to connect and project the AAN’s vision across the entire neurology community. Ultimately, they will play an integral role in realizing and delivering the academy’s diversification strategy.
The Women In Neurology programs develop women’s leaderships skills and promotes the value of women’s inclusion in key leadership positions to combat bias to support women in taking on leadership roles within the AAN.
Additionally, UCB continues to learn more about how to address patient needs throughout the healthcare journey. In support of this, UCB is presenting data on two exciting areas. First, in collaboration with multiple partners (STATinMED, New York City College of Technology, Emory University School of Medicine, University of Minnesota College of Pharmacy), UCB analyzed Medicaid formulary restrictions and the impact on health outcomes and cost. The results are important information for working with states to improve and expand access to anti-seizure medications for patients with epilepsy. Second, in collaboration with Partners Health in Boston, Massachusetts, UCB looked at factors associated with epilepsy-related care costs. The results are an important first step in understanding areas of healthcare that are better predictors of high cost, which will allow us to start developing specific education and collaboration projects to address these issues.
As passionate partners, UCB is extremely proud to be involved in these pioneering initiatives, and to be helping nurture a representative and inclusive neurology community.
Alongside the AAN, and all the delegates who will be gathering this week in Los Angeles, UCB is united in helping to improve management and patient experiences for people with neurological conditions.
In sharing our research, and in helping to grow and develop future neurology leaders, UCB continues its commitment to support patients to live their lives at their ideal.
Celebrating 70 years at the cutting edge of science and medicine, the AAN meeting is one of the most important and influential neurology gatherings in the world. It provides the global neurology community an opportunity to engage with and discuss exciting and cutting-edge science and research.
The meeting is also an ideal venue for organisations like UCB to engage with the experts from around the world – scientists, clinicians, healthcare providers and advocacy partners - and to discuss with them with the very latest research and thinking about our therapies and management approaches for diseases such as epilepsy, Parkinson's and restless legs syndrome (RLS).
As well as sharing our latest scientific research, this year, we are very proud to be supporting a number of AAN training and leadership initiatives.
UCB is pleased to sponsor the AAN Palatucci Advocacy Leadership Forum. This program builds neurologists’ capacity to advocate for the interests of their patients at the National and State levels. By completing this program neurologists are equipped to use media and public affairs strategies on real-time public policy issues that impact patients and providers.
The AAN Diversity Leadership immersion program identifies, orients and cultivates underrepresented minorities. During an interactive 9-month program, participants receive mentoring and executive coaching to improve their leadership skills, allowing them to connect and project the AAN’s vision across the entire neurology community. Ultimately, they will play an integral role in realizing and delivering the academy’s diversification strategy.
The Women In Neurology programs develop women’s leaderships skills and promotes the value of women’s inclusion in key leadership positions to combat bias to support women in taking on leadership roles within the AAN.
Additionally, UCB continues to learn more about how to address patient needs throughout the healthcare journey. In support of this, UCB is presenting data on two exciting areas. First, in collaboration with multiple partners (STATinMED, New York City College of Technology, Emory University School of Medicine, University of Minnesota College of Pharmacy), UCB analyzed Medicaid formulary restrictions and the impact on health outcomes and cost. The results are important information for working with states to improve and expand access to anti-seizure medications for patients with epilepsy. Second, in collaboration with Partners Health in Boston, Massachusetts, UCB looked at factors associated with epilepsy-related care costs. The results are an important first step in understanding areas of healthcare that are better predictors of high cost, which will allow us to start developing specific education and collaboration projects to address these issues.
As passionate partners, UCB is extremely proud to be involved in these pioneering initiatives, and to be helping nurture a representative and inclusive neurology community.
Alongside the AAN, and all the delegates who will be gathering this week in Los Angeles, UCB is united in helping to improve management and patient experiences for people with neurological conditions.
In sharing our research, and in helping to grow and develop future neurology leaders, UCB continues its commitment to support patients to live their lives at their ideal.
Leave a Comment